• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·0954.HK
Share

Changmao Biochemical Engineering Company Limited Stocks

HK$ 0.26Last Updated 30.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

HK$ 18.58M

HK$ 0.26
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Changmao Biochemical Engineering Company Limited, along with its affiliates, focuses on the production and global sale of organic acids. These products serve diverse industries, including food additive manufacturing, chemical production, and pharmaceuticals, reaching markets across Mainland China, Europe, the Asia Pacific region, the United States, and other international territories. Their extensive product line features fumaric acid, maleic acid, various forms of malic acid (L-, D-, and DL-), L(+)-, D(-)-, and DL-tartaric acids, L-aspartic acid, and aspartame. These compounds are utilized as essential food additives, pharmaceutical excipients, and active pharmaceutical ingredients, among other uses. Furthermore, the company is actively engaged in the research and development of medicinal and nutraceutical products, the manufacturing and distribution of additional food additives, the trade of organic acids, and property investment. Founded in 1992, Changmao Biochemical Engineering Company Limited is headquartered in Changzhou, People's Republic of China.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA, underprice

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 15:23

Morning in New York: The "bulls" are back in the AI sector

31.07.2026 15:00

Apnimed IPO: A company backed by an investor in Uber, X, and Revolut has gone public

31.07.2026 14:44

Tesla May Sell Its China Business to Merge with SpaceX — WSJ. Musk Denies This

31.07.2026 14:28

Lessons for Wall Street: 6 Questions About Aschenbrenner, the “AI Nostradamus,” and the Collapse of His Fund

31.07.2026 14:00

A Focus on Kazakhstan, Copper, and Low Costs: Why Analysts Have Faith in Arras Minerals

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026